U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H28O8
Molecular Weight 384.4208
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of .BETA.-ARTESUNATE

SMILES

C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4

InChI

InChIKey=FIHJKUPKCHIPAT-NKHDUEHSSA-N
InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16+,17-,18-,19-/m1/s1

HIDE SMILES / InChI

Molecular Formula C19H28O8
Molecular Weight 384.4208
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26615886 | https://www.google.com/patents/WO2013177420A3

.BETA.-ARTESUNATE is enantiomer of artesunate -- a medication used to treat malaria. β-ARTESUNATE is a prodrug that is rapidly converted to its active form dihydroartemisinin. This process involves hydrolysis of the 4-carbon ester group via plasma esterase enzyme. It is hypothesized that the cleavage of endoperoxide bridge in the pharmacophore of DHA generates reactive oxygen species (ROS), which increases oxidative stress and causes malarial protein damage via alkylation. .BETA.-ARTESUNATE have potential application as anticancer agent.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Artesunate and dihydroartemisinin (DHA): unusual decomposition products formed under mild conditions and comments on the fitness of DHA as an antimalarial drug.
2007-10
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
The in vitro cytotoxic activity of the compound 1 (BETA.-ARTESUNATE) was evaluated against sensitive human cancer cells (human hepatoma HepG2 cells, human lung adenocarcinoma A549 cells, human cervical carcinoma HeLa cells and human leukemic K562 cells), multidrug-resistant K562/ADR leukemia cells and human umbilical vein endothelial cells (HUVEC) by CCK-8 assay (drug exposure was for 72 h).
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:33:26 GMT 2025
Edited
by admin
on Mon Mar 31 23:33:26 GMT 2025
Record UNII
USD5X0Z99I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
.BETA.-ARTESUNATE
Common Name English
.BETA.-ARTESUNATE, (+)-
Preferred Name English
ARTESUNATE, .BETA.-
Common Name English
BUTANEDIOIC ACID, 1-((3R,5AS,6R,8AS,9R,10R,12R,12AR)-DECAHYDRO-3,6,9-TRIMETHYL-3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN-10-YL) ESTER
Common Name English
NSC-759817
Code English
Code System Code Type Description
NSC
759817
Created by admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
PRIMARY
CAS
182824-33-5
Created by admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID30861106
Created by admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
PRIMARY
FDA UNII
USD5X0Z99I
Created by admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
PRIMARY
PUBCHEM
65664
Created by admin on Mon Mar 31 23:33:26 GMT 2025 , Edited by admin on Mon Mar 31 23:33:26 GMT 2025
PRIMARY